BNIPL anticorps (Middle Region)
Aperçu rapide pour BNIPL anticorps (Middle Region) (ABIN928647)
Antigène
Voir toutes BNIPL AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Purification
- Purified
-
Immunogène
- BNIPL antibody was raised in rabbit using the middle region of BNIPL as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
BNIPL Blocking Peptide, (ABIN936528), is also available for use as a blocking control in assays to test for specificity of this BNIPL antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- BNIPL (BCL2/adenovirus E1B 19kD Interacting Protein Like (BNIPL))
-
Autre désignation
- BNIPL
-
Sujet
- BNIPL may be a bridge molecule between BCL2 and ARHGAP1/CDC42 in promoting cell death. Synonyms: Polyclonal BNIPL antibody, Anti-BNIPL antibody, BCL2/adenovirus E1B 19kD interacting protein like antibody, BNIP-S antibody, BNIPL-1 antibody, BNIPL-2 antibody, PP753 antibody.
Antigène
-